We are live on
!
Find out more
Macquarie Group Portfolio holdings
AUM
$23.2B
Turnover
20.23%
1-Year Est. Return
40.19%
This Fund
S&P 500
This Quarter
Est. Return
+12.48%
1 Year Est. Return
+40.19%
3 Year Est. Return
+109.35%
5 Year Est. Return
+140.11%
10 Year Est. Return
+481.97%
AUM
$81.5B
AUM Growth
+$965M
(+1.2%)
Cap. Flow
-$5.9B
Cap. Flow
% of AUM
-7.23%
Top 10 Holdings %
Top 10 Hldgs %
19.12%
Holding
1,800
New
97
Increased
519
Reduced
791
Closed
161
Avg Time Held
6.7
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$600M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$414M |
| 3 |
NVIDIA
NVDA
|
+$164M |
| 4 |
Intuit
INTU
|
+$163M |
| 5 |
Royal Caribbean
RCL
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$289M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$279M |
| 3 |
Oracle
ORCL
|
+$203M |
| 4 |
Amazon
AMZN
|
+$201M |
| 5 |
Meta Platforms (Facebook)
META
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.94% |
| 2 | Financials | 14.35% |
| 3 | Industrials | 10.63% |
| 4 | Healthcare | 10.53% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1526
NextCure
NXTC
$30.3M
| $69K | ﹤0.01% |
12,500
| – | – |
2019 Q4
22 quarters
|
|
1527
Madison Square Garden
MSGS
$9.84B
| $49.7K | ﹤0.01% |
+238
| New | +$45.8K |
2025 Q2
0 quarters
|
|
1528
CoreWeave
CRWV
$35.8B
| $46.5K | ﹤0.01% |
+285
| New | +$26.3K |
2025 Q2
0 quarters
|
|
1529
5E Advanced Materials
FEAM
$132M
| $45.2K | ﹤0.01% |
12,830
-5,074
| -28% | -$21.5K |
2023 Q3
7 quarters
|
|
1530
Suncor Energy
SU
$90.2B
| $44.9K | ﹤0.01% |
1,200
| – | – |
2024 Q2
4 quarters
|
|
1531
Bruker
BRKR
$8.7B
| $44.6K | ﹤0.01% |
+1,083
| New | +$41.8K |
2025 Q2
0 quarters
|
|
1532
DELISTED
Mersana Therapeutics
MRSN
| $44K | ﹤0.01% |
6,000
| – | – |
2020 Q2
20 quarters
|
|
1533
iShares Biotechnology ETF
IBB
$10.6B
| $42.1K | ﹤0.01% |
333
+36
| +12% | +$4.42K |
2025 Q1
1 quarter
|
|
1534
State Street SPDR S&P Biotech ETF
XBI
$9.84B
| $41.8K | ﹤0.01% |
504
+290
| +136% | +$23.1K |
2024 Q2
4 quarters
|
|
1535
Fusion Fuel Green
HTOO
$13.9M
| $41.7K | ﹤0.01% |
5,959
-9,968
| -63% | -$94.2K |
2024 Q3
3 quarters
|
|
1536
RenaissanceRe
RNR
$14.3B
| $40.8K | ﹤0.01% |
+168
| New | +$40.7K |
2025 Q2
0 quarters
|
|
1537
Teradata
TDC
$2.93B
| $39.4K | ﹤0.01% |
+1,764
| New | +$38.4K |
2025 Q2
0 quarters
|
|
1538
ThredUp
TDUP
$309M
| $35K | ﹤0.01% |
+4,668
| New | +$27.4K |
2025 Q2
0 quarters
|
|
1539
WEX
WEX
$6.21B
| $34.5K | ﹤0.01% |
+235
| New | +$31.6K |
2025 Q2
0 quarters
|
|
1540
Badger Meter
BMI
$3.67B
| $33.8K | ﹤0.01% |
+138
| New | +$31.3K |
2025 Q2
0 quarters
|
|
1541
DELISTED
Sandstorm Gold
SAND
| $33.8K | ﹤0.01% |
+3,599
| New | +$30.8K |
2025 Q2
0 quarters
|
|
1542
GitLab
GTLB
$9.45B
| $31.4K | ﹤0.01% |
+697
| New | +$31.9K |
2025 Q2
0 quarters
|
|
1543
OR Royalties Inc
OR
$6.59B
| $31.1K | ﹤0.01% |
+1,209
| New | +$29.1K |
2025 Q2
0 quarters
|
|
1544
BILL Holdings
BILL
$4.03B
| $31K | ﹤0.01% |
671
-120,425
| -99% | -$5.32M |
2020 Q1
21 quarters
|
|
1545
STMicroelectronics
STM
$41.4B
| $31K | ﹤0.01% |
1,005
-135,253
| -99% | -$3.36M |
2024 Q4
2 quarters
|
|
1546
Coca-Cola Consolidated
COKE
$13.8B
| $28.1K | ﹤0.01% |
+252
| New | +$30.4K |
2025 Q2
0 quarters
|
|
1547
Churchill Downs
CHDN
$5.74B
| $26.9K | ﹤0.01% |
266
-65,317
| -100% | -$6.39M |
2024 Q2
4 quarters
|
|
1548
Arm
ARM
$253B
| $25.2K | ﹤0.01% |
156
| – | – |
2023 Q3
7 quarters
|
|
1549
Occidental Petroleum Corp Warrants
OXY.WS
$36.6B
| $24.4K | ﹤0.01% |
1,177
| – | – |
2024 Q4
2 quarters
|
|
1550
NuScale Power
SMR
$2.46B
| $23.7K | ﹤0.01% |
+600
| New | +$15.1K |
2025 Q2
0 quarters
|
|
Similar funds
Macquarie Group's Q2 2025 Portfolio in Review
As of Q2 2025, Macquarie Group held 1,800 positions worth $81.5B, up 1.2% from $80.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Macquarie Group withdrew a net $5.9B in Q2 2025, closing 161 positions and reducing 791 holdings. Its most notable exit was Onto Innovation, an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
Against the trend, Macquarie Group opened a new position in Huron Consulting worth $58.2M.
- Macquarie Group's largest Q2 2025 buy was Huron Consulting: 422,852 shares worth $58.2M.
- Macquarie Group added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $600M increase.
- Macquarie Group's biggest Q2 2025 reduction was Apple, cutting an estimated $289M.
- Macquarie Group fully exited Onto Innovation in Q2 2025, selling an estimated $121M.
- Macquarie Group's ten largest holdings make up 19% of its $81.5B portfolio in Q2 2025.
- Macquarie Group opened 97 new positions and closed 161 in Q2 2025.
- Macquarie Group's portfolio value rose 1.2% quarter-over-quarter to $81.5B.
Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.